A comparison between intravenous and subcutaneous immunogobulin

British Journal of Nursing

Volumn 21, Issue 8, 2012, Pages

  Braine, Mary E ^a   Woodall, Amanda ^b  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Intravenous immunoglobulin; Multifocal motor neuropathy; Subcutaneous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NURSING; NURSING METHODOLOGY RESEARCH; POLYNEUROPATHY; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; INFUSIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NURSING METHODOLOGY RESEARCH; POLYNEUROPATHIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84862244130     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2012.21.sup8.s21     Document Type: Article

References (18)

1. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 26(2):12
2. Cats EA, van der Pol WL, Piepers S, Franssen H, Jacobs BC, van den Berg-Vos RM et al (2010) Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 75(9):818-25
3. Dacci P, Riva N, Scarlato M, Andresen I, Schmidt D, Comi G, Fazio R (2010) Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report. Neurol Sci 31(6):829-31
4. Daly PB, Evans JH, Kobayashi RH et al (1991) Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions. Ann Allergy 67(5):504-10
5. Department of Health (2008) Clinical Guidelines for immunoglobulin use. Department of Health (second edition). The Stationary Office, London. http://tinyurl.com/5ktoc2 (accessed 17 April 2012)
6. Eftimov F, Vermeulen M, de Haan RJ, van den Berg LH, van Schaik (2009) Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. J Peripher Nerv Syst 14(2):93-100
7. European Federation of Neurological Sciences/Peripheral Nerve Society (2010) Guideline on Management of Multifocal Motor Neuropathy. Report of a joint task force of the European Federation of Neurological Sciences and the Peripheral Nerve Society-first revision. J Peripher Nerv Syst 15(4):295-301
8. Gardulf A, Nicolay U, Asensio O, Bernatowska E, Bock A, Costa-Carvalho BT et al (2004) Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol 114(4):936-42 (Pubitemid 39330270)
9. Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Jakobsen J (2009) Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol 16(5):631-8
10. Harbo T, Andersen H, Jakobsen J (2010) Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Neurology 75(15):1377-80
11. Lange DJ, Weimer LH, Trojaborg W et al (2006) Multifocal motor neuropathy with conduction block: slow but not benign. Arch Neurol 63(12):1778-81 (Pubitemid 44925088)
12. Misbah SA, Baumann A, Fazio R, Dacci P, Schmidt DS, Burton J, Sturzenegger M (2011) A smooth transition protocol for patients with mutifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-ofconcept study. J Peripher Nerv Syst 16(2):92-7
13. Nobile-Orazio E, Cappellari A, Priori A (2005) Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 31(6):663-80 (Pubitemid 40734675)
14. Wasserman RL (2008) Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectations. Patient Prefer Adherence 2:163-6
15. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 30(6):473-83
16. Woodall A, Jones S (2010) Switching to home-based SCIg for Multifocal motor neuropathy (MMN). Br J Nurs 19(5 Suppl):S27-31
17. van Asseldonk JT, Franssen H, Van den Berg-Vos RM, Wokke JH, Van den Berg LH (2005) Multifocal motor neuropathy Lancet Neurol 4(5):309-19 (Pubitemid 40545042)
18. Van Schaik IN, van den Berg LH, de Haan RJ, Vermeulen M (2005) Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Cochrane Database Syst Rev 18(2):CD004429